Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Clinical trial NCT04890613 · RECRUITING
Trial details
- NCT number
- NCT04890613
- Sponsor
- Senhwa Biosciences, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-08
- Primary completion
- 2027-03-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.